UP Health Group


          Serving the Health Care Community in Michigan's Upper Peninsula

 
         Home
         Clinical
         The Committee
         Contact Us
         Links
         Policies
 


Committee News

           Next Meeting:  September 8, 2010
              
Packets mailed on or about September 1.

          May 12:  Last committee meeting.
             Thank you for participating.

          Thienopyridines reviewed in September.
          SNRIs reviewed in September.
          Uloric reviewed in May.

          Hyperuricemia agents reviewed in May.

          Proton pump inhibitors reviewed in May.

        Protocol for emergent warfarin reversal
             reviewed in May.
     

        Renvela reviewed in March.     

         Beta blockers reviewed in March.     

        Proton pump inhibitors reviewed in March.     

        Nplate reviewed in January.     

        Cleviprex reviewed in November.     

        Inhaled anesthetics reviewed in November.     

        Topical diclofenac reviewed in November.     

        Low-molecular-weight heparins
             reviewed in November.

 

New-Drug Reviews

  Uloric (febuxostat) (May 2009) 
  Renvela (sevelamer) (March 2009)

  Nplate (romiplostim) (January 2009)

  Cleviprex (clevidipine injectable emulsion) (November 2008)

  Entereg (alvimopan) (September 2008)

   
 

 
 
 

Drug-Class Reviews

  SNRIs (September 2009) 
  Thienopyridines (September 2009)

  Hyperuricemia Agents (May 2009)

  Proton Pump Inhibitors (May 2009)

  Beta Blockers (March 2009)

  Proton Pump Inhibitors (March 2009)